Effect of Risperidone on Prolactinoma: A Case Report

Pharmacopsychiatry

Volumn 37, Issue 1, 2004, Pages 41-42

  Mendhekar, D N ^a   Jiloha, R C ^a   Srivastava, P K ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; OLANZAPINE; PROLACTIN; RISPERIDONE;

ADD ON THERAPY; ADULT; ARTICLE; BIPOLAR MANIA; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; GALACTORRHEA; HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TREATMENT OUTCOME; TUMOR REGRESSION;

ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GALACTORRHEA; HUMANS; LITHIUM CARBONATE; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PROLACTINOMA; RISPERIDONE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1242292401     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815474     Document Type: Article

References (10)

1. Baptista T, Lacruz T, Angeles F, Silvera R, DE Medoza MT, Hernadez L. Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry 2001; 34(6): 223-231
2. Green AI, Brown WA. Prolactin and neuroleptic drugs. Neurol Clin 1988; 6: 213-223
3. Szymanski S, Lieberman J, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane JK, Woerner M, Cooper T. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995; 152: 698-703
4. Shiwach RS, Carmody TJ. Prolactogenic effects of risperidone in male patients - a preliminary study. Acta Psychiatr Scand 1998; 98: 81-83
5. Robbins RJ, Kern PA, Thomson II TL. Interaction between thioridazine and bromocriptine in a patient with a prolactin secreting pituitary adenoma. Am J Medicine 1984; 76: 921-923
6. Weingarten JC, Thompson TL. The effect of thioridazine on prolactinoma growth in a schizophrenic man; a case report. Gen Hosp Psychiatry 1985; 7: 364-6
7. Daradkeh TK, Aljouni KM. The effect of neuroleptics on prolactinoma growths in a Jordanian schizophrenic girl. Acta Psychiatr Scand 1988; 77: 228-9
8. Pal JK, Sarino WA. Effect of risperidone on prolactinoma growth in psychotic woman. Psychosom Med, 2000 Sep-Oct; 62(5): 736-8
9. Tollin SR. Use of dopamine agonist bromocriptine and cabergoline in the management of risperidone induced hyperprolactinemia in-patient with psychotic disorder. J Endocrinol Invest 2000; 23(11): 765-770
10. Canuso CM, Hanau M, Jhamb KK, Green AI. Olanzapine use in women with antipsychotic induced hyperprolactinemia. Am J Psychiatry Oct 1998; 155(10): 1458